FITORE VULA: Open Payments
NPI 1164927497 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,115 in 91 payments from 19 companies in 2025. Trend: 2023 $1,844 · 2024 $2,716 · 2025 $3,115
Food & beverage: $3,026Education: $89
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $407 |
| Janssen Biotech, Inc. | 6 | $299 |
| Gilead Sciences, Inc. | 3 | $272 |
| ABBVIE INC. | 13 | $254 |
| PFIZER INC. | 9 | $249 |
| GENZYME CORPORATION | 5 | $240 |
| Madrigal Pharmaceuticals | 5 | $215 |
| Phathom Pharmaceuticals, Inc. | 5 | $177 |
| Ardelyx, Inc. | 5 | $177 |
| Novo Nordisk Inc | 2 | $145 |
Products named: XIFAXAN, TREMFYA, DUPIXENT, Livdelzi, REZDIFFRA, VELSIPITY, VOQUEZNA, IBSRELA.
Industry payments across VA — which companies pay providers there.
